A Phase I Randomized Study of a Specifically Engineered, pH-Sensitive PCSK9 Inhibitor RN317 (PF-05335810) in Hypercholesterolemic Subjects on Statin Therapy.
about
A Phase I Randomized Study of a Specifically Engineered, pH-Sensitive PCSK9 Inhibitor RN317 (PF-05335810) in Hypercholesterolemic Subjects on Statin Therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A Phase I Randomized Study of ...... ic Subjects on Statin Therapy.
@en
A Phase I Randomized Study of ...... ic Subjects on Statin Therapy.
@nl
type
label
A Phase I Randomized Study of ...... ic Subjects on Statin Therapy.
@en
A Phase I Randomized Study of ...... ic Subjects on Statin Therapy.
@nl
prefLabel
A Phase I Randomized Study of ...... ic Subjects on Statin Therapy.
@en
A Phase I Randomized Study of ...... ic Subjects on Statin Therapy.
@nl
P2093
P2860
P356
P1476
A Phase I Randomized Study of ...... ic Subjects on Statin Therapy.
@en
P2093
B Gumbiner
M Levisetti
P D Garzone
P2860
P356
10.1111/CTS.12430
P407
P577
2016-11-17T00:00:00Z